Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №10 (2025) > Previously undiagnosed tyrosine metabolism disorder – alkaptonuria (a clinical case)

Previously undiagnosed tyrosine metabolism disorder – alkaptonuria (a clinical case)

Nikita M. Nikitin , Margarita A. Gromova , Mikhail A. Bolotnikov , Ekaterina S. Biryuk

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Alkaptonuria is a rare metabolic disorder in the catabolic pathway of phenylalanine and tyrosine, which is characterized by excessive release of homogentisic acid in the urine, ochronosis and arthropathy of the spine and large joints. The population frequency of alkaptonuria is 1 case per 250,000 – 1,000,000 people. The autosomal recessive nature of inheritance, which often does not result in family accumulation, and the late development of clinical symptoms (after 40 years) lead to practitioners rarely encountering this pathology and not having indications of familial or congenital nature of the disease makes it difficult to make a diagnosis. It is necessary to raise awareness among healthcare professionals about the symptoms of alkaptonuria, diagnostic methods, and management of patients with this disease. In this article, we describe the case of a 59-year-old man with severe clinical manifestations of alkaptonuria.
Keywords: alkaptonuria, arthritis, dark urine, homogentisic acid, pigmentation, congenital metabolic disorders, clinical case.

About the Author

Nikita M. Nikitin , Margarita A. Gromova , Margarita A. Gromova , Mikhail A. Bolotnikov , Ekaterina S. Biryuk
Nikita M. Nikitin1, Margarita A. Gromova2,4, Mikhail A. Bolotnikov3, Ekaterina S. Biryuk4

1 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
2 Pirogov Russian National Research Medical University, Moscow, Russia;
3 Klinika Bud’ Zdorov, LLC, Moscow, Russia;
4 JSC “K+31 West”, Moscow, Russia
m.igarasi@yandex.ru

References

1. Rovenský J et al. (eds). Alkaptonuria and Ochronosis. Springer; 2015. DOI: 10.1007/978-3-319-15108-3_25
2. Aquaron R. Alkaptonuria: a very rare metabolic disorder. Indian 
J Biochem Biophys 2013 Oct;50(5):339-44 . URL: http://nopr.niscair. res.in/handle/123456789/22650
3. Gallagher JA, Dillon JP, Sireau N et al. Alkaptonuria: An example of a «fundamental disease» – A rare disease with important lessons for more common disorders. Semin Cell Dev Biol 2016, Apr;52:53-7. DOI: 10.1016/j.semcdb.2016.02.020
4. Zatkova A. An update on molecular genetics of Alkaptonuria (AKU). 
J Inherit Metab Dis 2011 Dec;34(6):1127-36. DOI: 10.1007/s10545–011–9363-z
5. Orphanet. URL: https://www.orpha.net/
6. Nemethova M, Radvanszky J, Kadasi L et al. Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on ‘black bone disease’ in Italy. Eur J Hum Genet 2016, Jan;24(1):66-72. DOI: 10.1038/ejhg.2015.60
7. Ranganath L, Taylor AM, Shenkin A et al. Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriers. J Inherit Metab Dis 2011;34:723-30. DOI: 10.1007/ s10545-011-9282-z
8. Близнюков В.В., Коваленко А.Н., Румакин В.П. Вторичный деформирующий гонартроз на фоне охроноза (случай из клинической практики). Травматология и ортопедия России. 2013;(2):111-5. DOI: 10.21823/2311-2905-2013-2-111-115
Bliznyukov V.V., Kovalenko A.N., Rumakin V.P. Knee degenerative osteoarthritis secondary to ochronosis (case report). Traumatology and Orthopedics of Russia. 2013;(2):111-5. DOI: 10.21823/2311-2905-2013-2-111-115 (in Russian).
9. Горожанин А.В., Кузин А.В., Блудов А.Б. и др. Тяжелое поражение позвоночника при алкаптонурии. Описание клинического случая. Журнал «Вопросы нейрохирургии» имени Н.Н. Бурденко. 2021;85(5):104-9. DOI: 10.17116/neiro202185051104
Gorozhanin A.V., Kuzin A.V., Bludov A.B. et al. Severe spine lesion following alkaptonuria. Case report. Burdenko's Journal of Neurosurgery. 2021;85(5):104-9. DOI: 10.17116/neiro202185051104 (in Russian, in English).
10. Сердюк А.В., Ковражкина Е.А., Кулькова А.О. Алкаптонурия у пациента с вертебрально-базилярной недостаточностью: описание случая и обзор литературы. Consilium Medicum. 2017;19(2):51-5.
Serdiuk A.V., Kovrazhkina E.A., Kulkova A.O. Alcaptonuria patient with vertebrobasilar insufficiency: case report and literature review. Consilium Medicum. 2017;19(2):51-5 (in Russian).

11. O'Brien WM, La Du BN, Bunin JJ. Biochemical, pathologic, and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy. Review of world literature. Am J Med 1963;34:813-38.
12. Jafri K, Gensler LS, Link TM. Clinical images: Ochronotic arthropathy. Arthritis Rheum 2017;69(11):2208. DOI: 10.1002/art.40184
13. Ranga U, Aiyappan SK, Shanmugam N, Veeraiyan S. Ochronotic spondyloarthropathy. J Clin Diagn Res 2013;7(2):403-4. DOI: 10.7860/JCDR/2013/4308.2782
14. Lange U, Müller-Ladner U, Dischereit G. Severe osteoarthritic manifestations of ochronosis. Z Rheumatol 2014;73(5):420-3. DOI: 10.1007/s00393-013-1343-215
15. Millucci L, Bernardini G, Spreafico A et al. Histological and ultrastructural characterization of alkaptonuric tissues. Calcif Tissue Int 2017;101(1):50-64. DOI: 10.1007/s00223-017-0260-9
16. Раденска-Лоповок С.Г., Тимакова А.А., Кузин А.В., Мурылев В.Ю. Алкаптонурия – морфологические изменения тканей суставов. Обзор литературы и собственные наблюдения. Архив патологии 2020;82(4):41-6. DOI: 10.17116/patol20208204141
Radenska-Lopovok S.G., Timakova A.A., Kuzin A.V., Murylev V.Yu. Alkaptonuria – morphological lesions of articular tissues. Literature review and case report. Russian Journal of Archive of Pathology 2020;82(4):41-6. DOI: 10.17116/patol20208204141 (in Russian).
17. de Haas V, Carbasius Weber EC, de Klerk JB et al. The success of dietary protein restriction in alkaptonuria patients is age-dependent.
J Inherit Metab Dis 1998;21:791-8. DOI: 10.1023/a:1005410416482
18. Mayatepek E, Kallas K, Anninos A, Müller E. Effects of ascorbic acid and low-protein diet in alkaptonuria. Eur J Pediatr 1998;157:867-8. DOI: 10.1007/s004310050956
19. Wolff JA, Barshop B, Nyhan WL et al. Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and an ontogenic effect in infancy. Pediatr Res 1989;26:140-4. DOI: 10.1203/00006450-198908000-00015
20. Introne WJ, Perry MB, Troendle J et al. A 3-year randomized therapeutic trial of nitisinone in alkaptonuria. Mol Genet Metab 2011;103:307-14. DOI: 10.1016/j.ymgme.2011.04.016
21. Агзамов Д.С., Сайковский Р.С. Охроноз, его последствия и возможности хирургического лечения. Клиническая практика. 2010;1(1):21-4. DOI: 10.17816/clinpract1121-24
Agzamov D.S., Saykovskiy R.S. Ochronosis, its consequences and possibilities of surgical treatment. Journal of Clinical Practice. 2010;1(1):21-4. DOI: 10.17816/clinpract1121-24 (in Russian).
22. Karaoglu S, Karaaslan F, Mermerkaya MU. Long-term result of arthroplasty in the treatment of a case of ochronotic arthropathy. Acta Orthop Traumatol Turc 2016 Oct;50(5):584-6. DOI: 10.1016/j.aott.2016.08.018

For citation:Nikitin N.M., Gromova M.A., Bolotnikov M.A., Biryuk E.S. Previously undiagnosed tyrosine metabolism disorder – alkaptonuria (a clinical case). Clinical review for general practice. 2025; 6 (10): 94–100 (In Russ.). DOI: 10.47407/kr2025.6.10.00698


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru